Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs
Neurology Today in 515 Mai

Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.

Episoder(100)

November 18 - Issue Introduction

November 18 - Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 18, 2021 issue.

19 Nov 20215min

November 4- Issue Introduction

November 4- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.

8 Nov 20215min

October 21- Issue Introduction

October 21- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.

21 Okt 20215min

October 7- Issue Introduction

October 7- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.

7 Okt 20215min

Populært innen Premium

papaya
krimpodden-vg
giver-og-gjengen-vg
avhort
aftenpodden
tore-og-haralds-podkast
storefri-med-mikkel-og-herman
podme-krim
harm-og-hegseth
aftenpodden-usa
topp-3-med-mads-og-rasmus
ida-med-hjertet-i-handen
big-5-med-nils-og-harald-2
hvordan-har-du-det-mann
konspirasjonspodden
tusvik-tnne
fastlegen
verdens-verste
nare-venner
popradet